$PREJF
PARTNERRE LTD Stock $prejf

$prejf Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000091142115000046 Filed on October 30, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$1.379B	$1.399B	$1.643B
YoY Change	-17.08%	-14.85%	5.05%
Cost Of Revenue	$767.0M	$804.0M	$960.0M
YoY Change	-11.84%	-16.25%	27.83%
Gross Profit	$612.0M	$261.0M	$275.0M
YoY Change	-22.82%	-5.09%	-28.94%
Gross Profit Margin	44.38%	18.66%	16.74%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$311.0M	$347.0M	$322.0M
YoY Change	-4.31%	7.76%	13.78%
% of Gross Profit	50.82%	132.95%	117.09%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$12.00M	$12.00M	$12.00M
YoY Change	0.0%	0.0%	0.0%
% of Operating Profit
Other Income/Expense, Net	$120.0M	$416.0M	$108.0M
YoY Change	-2.44%	285.19%	0.0%
Pretax Income	$169.0M	-$209.0M	$242.0M
YoY Change	-49.4%	-186.36%	-39.8%
Income Tax	-$3.000M	$17.00M	$46.00M
% Of Pretax Income	-1.78%		19.01%
Net Earnings	$177.0M	-$229.0M	$196.0M
YoY Change	-36.1%	-216.84%	-41.32%
Net Earnings / Revenue	12.84%	-16.37%	11.93%
Basic Earnings Per Share	$3.39	-$5.08	$3.68
Diluted Earnings Per Share	$3.30	-$5.08	$3.60
COMMON SHARES
Basic Shares Outstanding	47.91M shares	47.87M shares	49.51M shares
Diluted Shares Outstanding		47.87M shares	50.68M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.577B	$1.256B	$1.519B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$456.4M	$456.4M	$456.4M
YoY Change	0.0%	0.0%
Intangibles	$133.0M	$139.3M	$166.1M
YoY Change	-16.66%	-16.13%	-14.01%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$21.41B	$22.03B	$23.21B
YoY Change	-3.88%	-5.09%	0.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$14.50B	$15.25B	$16.14B
YoY Change	-4.37%	-5.53%	-2.26%
SHAREHOLDERS EQUITY
Retained Earnings	$6.147B	$6.020B	$6.041B
YoY Change	-1.98%	-0.35%	16.55%
Common Stock	$87.24M	$87.24M	$87.14M
YoY Change	0.0%	0.11%	0.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.267B	$3.269B	$3.076B
YoY Change	0.24%	6.28%	18.01%
Treasury Stock Shares	39.30M shares	39.34M shares	37.79M shares
Shareholders Equity	$6.901B	$6.775B	$7.014B
YoY Change
Total Liabilities & Shareholders Equity	$21.41B	$22.03B	$23.21B
YoY Change	-3.88%	-5.09%	0.3%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	$177.0M	-$229.0M	$196.0M
YoY Change	-36.1%	-216.84%	-41.32%
Depreciation, Depletion And Amortization	$311.0M	$347.0M	$322.0M
YoY Change	-4.31%	7.76%	13.78%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000911421
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47908360	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	PARTNERRE LTD.
	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014Q3	pre	Underwriting Result UnderwritingResult	169000000	USD
	pre	Underwriting Result UnderwritingResult	366000000	USD
CY2015Q3	pre	Underwriting Result UnderwritingResult	-152000000	USD
	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
	dei	Trading Symbol TradingSymbol	PRE
CY2014Q4	pre	Derivative Asset Financial Instruments Not Offset DerivativeAssetFinancialInstrumentsNotOffset	766000	USD
CY2015Q3	pre	Derivative Asset Financial Instruments Not Offset DerivativeAssetFinancialInstrumentsNotOffset	520000	USD
CY2014Q4	pre	Derivative Liability Financial Instruments Not Offset DerivativeLiabilityFinancialInstrumentsNotOffset	766000	USD
CY2015Q3	pre	Derivative Liability Financial Instruments Not Offset DerivativeLiabilityFinancialInstrumentsNotOffset	520000	USD
CY2014Q4	pre	Funds Held Directly Managed FundsHeldDirectlyManaged	608853000	USD
CY2015Q3	pre	Funds Held Directly Managed FundsHeldDirectlyManaged	595677000	USD
CY2014Q4	pre	Funds Held Directly Managed Cost FundsHeldDirectlyManagedCost	600379000	USD
CY2015Q3	pre	Funds Held Directly Managed Cost FundsHeldDirectlyManagedCost	589385000	USD
CY2014Q4	pre	Funds Held Directly Managed Investments Carried At Fair Value FundsHeldDirectlyManagedInvestmentsCarriedAtFairValue	472593000	USD
CY2015Q3	pre	Funds Held Directly Managed Investments Carried At Fair Value FundsHeldDirectlyManagedInvestmentsCarriedAtFairValue	415357000	USD
	pre	Increase Decrease From Issuance Or Sale Of Equity Net Of Taxes Withheld In A Net Share Settlement IncreaseDecreaseFromIssuanceOrSaleOfEquityNetOfTaxesWithheldInANetShareSettlement	12639000	USD
	pre	Increase Decrease From Issuance Or Sale Of Equity Net Of Taxes Withheld In A Net Share Settlement IncreaseDecreaseFromIssuanceOrSaleOfEquityNetOfTaxesWithheldInANetShareSettlement	3139000	USD
	pre	Increase Decrease In Funds Held By Reinsured Companies And Funds Held Directly Managed IncreaseDecreaseInFundsHeldByReinsuredCompaniesAndFundsHeldDirectlyManaged	138659000	USD
	pre	Increase Decrease In Funds Held By Reinsured Companies And Funds Held Directly Managed IncreaseDecreaseInFundsHeldByReinsuredCompaniesAndFundsHeldDirectlyManaged	81465000	USD
	pre	Increase Decrease In Net Tax Assets And Liabilities IncreaseDecreaseInNetTaxAssetsAndLiabilities	-27792000	USD
	pre	Increase Decrease In Net Tax Assets And Liabilities IncreaseDecreaseInNetTaxAssetsAndLiabilities	-68588000	USD
	pre	Increase Decrease In Reinsurance Balances Net IncreaseDecreaseInReinsuranceBalancesNet	-565187000	USD
	pre	Increase Decrease In Reinsurance Balances Net IncreaseDecreaseInReinsuranceBalancesNet	-703147000	USD
	pre	Increase Decrease In Reinsurance Recoverable On Paid And Unpaid Losses Net Of Ceded Premiums Payable IncreaseDecreaseInReinsuranceRecoverableOnPaidAndUnpaidLossesNetOfCededPremiumsPayable	32421000	USD
	pre	Increase Decrease In Reinsurance Recoverable On Paid And Unpaid Losses Net Of Ceded Premiums Payable IncreaseDecreaseInReinsuranceRecoverableOnPaidAndUnpaidLossesNetOfCededPremiumsPayable	53086000	USD
	pre	Increase Decrease In Unpaid Losses And Loss Expenses Including Life Policy Benefits IncreaseDecreaseInUnpaidLossesAndLossExpensesIncludingLifePolicyBenefits	144663000	USD
	pre	Increase Decrease In Unpaid Losses And Loss Expenses Including Life Policy Benefits IncreaseDecreaseInUnpaidLossesAndLossExpensesIncludingLifePolicyBenefits	298428000	USD
CY2014Q3	pre	Losses And Loss Expenses And Life Policy Benefits Segment Disclosure LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure	960000000	USD
	pre	Losses And Loss Expenses And Life Policy Benefits Segment Disclosure LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure	2593000000	USD
CY2015Q3	pre	Losses And Loss Expenses And Life Policy Benefits Segment Disclosure LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure	804000000	USD
	pre	Losses And Loss Expenses And Life Policy Benefits Segment Disclosure LossesAndLossExpensesAndLifePolicyBenefitsSegmentDisclosure	2390000000	USD
CY2014Q4	pre	Net Tax Assets NetTaxAssets	6876000	USD
CY2015Q3	pre	Net Tax Assets NetTaxAssets	72257000	USD
CY2014Q4	pre	Net Tax Liabilities NetTaxLiabilities	240989000	USD
CY2015Q3	pre	Net Tax Liabilities NetTaxLiabilities	231223000	USD
CY2014Q4	pre	Other Invested Assets Carried At Fair Value OtherInvestedAssetsCarriedAtFairValue	111476000	USD
CY2015Q3	pre	Other Invested Assets Carried At Fair Value OtherInvestedAssetsCarriedAtFairValue	144487000	USD
CY2014Q4	pre	Preference Shares Aggregate Liquidation Value PreferenceSharesAggregateLiquidationValue	853750000	USD
CY2015Q3	pre	Preference Shares Aggregate Liquidation Value PreferenceSharesAggregateLiquidationValue	853750000	USD
	pre	Underwriting Result UnderwritingResult	16000000	USD
CY2014Q3	pre	Weighted Average Number Of Potentially Dilutive Common Shares And Common Share Equivalents Outstanding WeightedAverageNumberOfPotentiallyDilutiveCommonSharesAndCommonShareEquivalentsOutstanding	1166345	shares
	pre	Weighted Average Number Of Potentially Dilutive Common Shares And Common Share Equivalents Outstanding WeightedAverageNumberOfPotentiallyDilutiveCommonSharesAndCommonShareEquivalentsOutstanding	1104385	shares
CY2015Q3	pre	Weighted Average Number Of Potentially Dilutive Common Shares And Common Share Equivalents Outstanding WeightedAverageNumberOfPotentiallyDilutiveCommonSharesAndCommonShareEquivalentsOutstanding	0	shares
	pre	Weighted Average Number Of Potentially Dilutive Common Shares And Common Share Equivalents Outstanding WeightedAverageNumberOfPotentiallyDilutiveCommonSharesAndCommonShareEquivalentsOutstanding	0	shares
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	304728000	USD
CY2015Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	285316000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-82519000	USD
CY2014Q3	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1412000	USD
	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	3209000	USD
CY2015Q3	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-39533000	USD
	us-gaap	Cumulative Translation Adjustment Net Of Tax Period Increase Decrease CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	-33936000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-70552000	USD
CY2014Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	158737000	USD
CY2015Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	142892000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-34083000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-68827000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3949665000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3971974000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7003000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21007000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6768000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20303000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	134470	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	135681	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1168383	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1207482	shares
CY2014Q4	us-gaap	Assets Assets	22270357000	USD
CY2015Q3	us-gaap	Assets Assets	22025228000	USD
CY2014Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	1361280000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	4695327000	USD
CY2015Q3	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	1267961000	USD
	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	4448907000	USD
CY2014Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1400952000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	3855759000	USD
CY2015Q3	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1607964000	USD
	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	4039204000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1496485000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1519287000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1313468000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1256304000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22802000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-57164000	USD
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.67
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.01
CY2015Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.70
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.10
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87237220	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87237220	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	87237000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	87237000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	198578000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	781602000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-267720000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-106874000	USD
CY2015Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	14184000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	42551000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	14.58
CY2014Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	23850000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-16359000	USD
CY2015Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-35554000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-88461000	USD
CY2014Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2015Q3	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2014Q4	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.08
CY2014Q3	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2015Q3	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0	USD
CY2014Q3	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-7300000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	13225000	USD
CY2014Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	14184000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	42551000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.40
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	14.26
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.40
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-37669000	USD
CY2014Q3	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	321756000	USD
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	888937000	USD
CY2015Q3	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	346520000	USD
	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	905774000	USD
CY2014Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	661186000	USD
CY2015Q3	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	684380000	USD
CY2014Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	92973000	USD
CY2015Q3	us-gaap	Deposit Contracts Assets DepositContractsAssets	83729000	USD
CY2014Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	70325000	USD
CY2015Q3	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	42336000	USD
CY2014Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2015Q3	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2014Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	8536000	USD
CY2015Q3	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	9440000	USD
CY2014Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	14858000	USD
CY2015Q3	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	47430000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	21521000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	25049000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	21521000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	25049000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	12219000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	15089000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	27977000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	52062000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	27977000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	52062000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	12353000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	4112000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	-6456000	USD
CY2015Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	-27013000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-35729000	USD
CY2015Q3	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	17802000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	4782000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-7448000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	11407000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	19156000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	5038000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	46591000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	205364000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	108690000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	469792000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	0	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	62924000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	176688000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	94650000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	487439000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	712306000	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	776170000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	752389000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	769384000	USD
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	723579000	USD
CY2015Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	756775000	USD
CY2014Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-110667000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	154246000	USD
CY2015Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-116642000	USD
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-347173000	USD
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8206000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	10900000	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-22413000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15657000	USD
CY2014Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	765905000	USD
CY2015Q3	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	671572000	USD
CY2014Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-34420000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	273468000	USD
CY2015Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-133017000	USD
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-273107000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	456380000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	456380000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	275000000	USD
	us-gaap	Gross Profit GrossProfit	681000000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	261000000	USD
	us-gaap	Gross Profit GrossProfit	679000000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	241641000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	958076000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-208741000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11827000	USD
CY2014Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5294000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	16283000	USD
CY2015Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3231000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1564000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	45617000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	186363000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17170000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82990000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	243396000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	178830000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	83758000	USD
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	52580000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10207000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-13368000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	336384000	USD
	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	191234000	USD
CY2014Q3	us-gaap	Increase Decrease In Unearned Premiums Net IncreaseDecreaseInUnearnedPremiumsNet	213924000	USD
	us-gaap	Increase Decrease In Unearned Premiums Net IncreaseDecreaseInUnearnedPremiumsNet	-336384000	USD
CY2015Q3	us-gaap	Increase Decrease In Unearned Premiums Net IncreaseDecreaseInUnearnedPremiumsNet	221737000	USD
	us-gaap	Increase Decrease In Unearned Premiums Net IncreaseDecreaseInUnearnedPremiumsNet	-191235000	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	159604000	USD
CY2015Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	139301000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	12241000	USD
	us-gaap	Interest Expense InterestExpense	36719000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	12249000	USD
	us-gaap	Interest Expense InterestExpense	36742000	USD
	us-gaap	Interest Paid InterestPaid	24630000	USD
	us-gaap	Interest Paid InterestPaid	24630000	USD
CY2014Q3	us-gaap	Investment Income Net InvestmentIncomeNet	118176000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	365010000	USD
CY2015Q3	us-gaap	Investment Income Net InvestmentIncomeNet	117054000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	341877000	USD
CY2014Q4	us-gaap	Investments Investments	15299764000	USD
CY2015Q3	us-gaap	Investments Investments	14475450000	USD
CY2014Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	15585006000	USD
CY2015Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	14690574000	USD
CY2014Q4	us-gaap	Junior Subordinated Notes JuniorSubordinatedNotes	70989000	USD
CY2015Q3	us-gaap	Junior Subordinated Notes JuniorSubordinatedNotes	70989000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	15165946000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	15247879000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22270357000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22025228000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	9745806000	USD
CY2015Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	9522225000	USD
CY2014Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	2050107000	USD
CY2015Q3	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	2123028000	USD
CY2014Q4	us-gaap	Minority Interest MinorityInterest	55501000	USD
CY2015Q3	us-gaap	Minority Interest MinorityInterest	2212000	USD
	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	14265000	USD
	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	55820000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-520187000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-266762000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2579000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	137698000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	583237000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	107629000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	196398000	USD
	us-gaap	Net Income Loss NetIncomeLoss	778082000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-229137000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-72130000	USD
CY2014Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	4920000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9914000	USD
CY2015Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2531000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	182214000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	735531000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-243321000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-114681000	USD
CY2014Q4	us-gaap	Other Assets OtherAssets	45603000	USD
CY2015Q3	us-gaap	Other Assets OtherAssets	38450000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	989000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	979000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1163000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-164000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2180000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3520000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-38583000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-34744000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-221000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-668000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-213000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-644000	USD
CY2014Q3	us-gaap	Other Expenses OtherExpenses	108615000	USD
	us-gaap	Other Expenses OtherExpenses	327149000	USD
CY2015Q3	us-gaap	Other Expenses OtherExpenses	415818000	USD
	us-gaap	Other Expenses OtherExpenses	670334000	USD
CY2014Q3	us-gaap	Other Income OtherIncome	2223000	USD
	us-gaap	Other Income OtherIncome	11892000	USD
CY2015Q3	us-gaap	Other Income OtherIncome	3056000	USD
	us-gaap	Other Income OtherIncome	7584000	USD
CY2014Q4	us-gaap	Other Investments OtherInvestments	298827000	USD
CY2015Q3	us-gaap	Other Investments OtherInvestments	344720000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4822000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	129440000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	374557000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	71376000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	144004000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	142705000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	95168000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	126756000	USD
CY2014Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	959543000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2592847000	USD
CY2015Q3	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	804196000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	2390394000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	34150000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	34150000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	34150000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	34150000	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	34150000	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	34150000	USD
CY2014Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	1556614000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	4163465000	USD
CY2015Q3	us-gaap	Premiums Earned Net PremiumsEarnedNet	1412130000	USD
	us-gaap	Premiums Earned Net PremiumsEarnedNet	3974677000	USD
CY2014Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2454850000	USD
CY2015Q3	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	3079002000	USD
CY2014Q3	us-gaap	Premiums Written Net PremiumsWrittenNet	1342690000	USD
	us-gaap	Premiums Written Net PremiumsWrittenNet	4499849000	USD
CY2015Q3	us-gaap	Premiums Written Net PremiumsWrittenNet	1190393000	USD
	us-gaap	Premiums Written Net PremiumsWrittenNet	4165912000	USD
	us-gaap	Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment	527367000	USD
	us-gaap	Proceeds From Maturities Repayments And Calls Of Trading Securities Heldforinvestment ProceedsFromMaturitiesRepaymentsAndCallsOfTradingSecuritiesHeldforinvestment	548688000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	70750000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	50497000	USD
CY2014Q3	us-gaap	Profit Loss ProfitLoss	201318000	USD
	us-gaap	Profit Loss ProfitLoss	787996000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-229142000	USD
	us-gaap	Profit Loss ProfitLoss	-69599000	USD
CY2014Q4	us-gaap	Reinsurance Payable ReinsurancePayable	182395000	USD
CY2015Q3	us-gaap	Reinsurance Payable ReinsurancePayable	288402000	USD
CY2014Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	246158000	USD
CY2015Q3	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	329834000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6270811000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6019786000	USD
CY2014Q3	us-gaap	Revenues Revenues	1642593000	USD
	us-gaap	Revenues Revenues	4813835000	USD
CY2015Q3	us-gaap	Revenues Revenues	1399223000	USD
	us-gaap	Revenues Revenues	4051031000	USD
CY2014Q4	us-gaap	Senior Notes SeniorNotes	750000000	USD
CY2015Q3	us-gaap	Senior Notes SeniorNotes	750000000	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	25678000	USD
CY2015Q3	us-gaap	Short Term Investments ShortTermInvestments	100365000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	7013980000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	7048910000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	6775137000	USD
CY2014Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7066256000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7104411000	USD
CY2015Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6777349000	USD
CY2014Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	13918745000	USD
CY2015Q3	us-gaap	Trading Securities Debt TradingSecuritiesDebt	13026249000	USD
CY2014Q4	us-gaap	Trading Securities Debt Amortized Cost TradingSecuritiesDebtAmortizedCost	13489633000	USD
CY2015Q3	us-gaap	Trading Securities Debt Amortized Cost TradingSecuritiesDebtAmortizedCost	12810504000	USD
CY2014Q4	us-gaap	Trading Securities Equity TradingSecuritiesEquity	1056514000	USD
CY2015Q3	us-gaap	Trading Securities Equity TradingSecuritiesEquity	1004116000	USD
CY2014Q4	us-gaap	Trading Securities Equity Cost TradingSecuritiesEquityCost	843429000	USD
CY2015Q3	us-gaap	Trading Securities Equity Cost TradingSecuritiesEquityCost	938826000	USD
CY2014Q4	us-gaap	Trading Securities Short Term Investments Amortized Cost TradingSecuritiesShortTermInvestmentsAmortizedCost	25699000	USD
CY2015Q3	us-gaap	Trading Securities Short Term Investments Amortized Cost TradingSecuritiesShortTermInvestmentsAmortizedCost	100270000	USD
CY2014Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	39400936	shares
CY2015Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	39335464	shares
CY2014Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3258870000	USD
CY2015Q3	us-gaap	Treasury Stock Value TreasuryStockValue	3269183000	USD
CY2014Q4	us-gaap	Unearned Premiums UnearnedPremiums	1750607000	USD
CY2015Q3	us-gaap	Unearned Premiums UnearnedPremiums	1934360000	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50681325	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51566134	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47866040	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47722833	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49514980	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50461749	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47866040	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47722833	shares
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Intercompany accounts and transactions have been eliminated.</font></div></div>
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3. Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2015, the Financial Accounting Standards Board (FASB) issued updated guidance on the consolidation of voting interest entities and variable interest entities. The guidance is effective for interim and annual periods beginning after December 15, 2015, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this guidance on its Consolidated Financial Statements and disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2015, the FASB issued updated guidance on disclosures related to short-duration insurance contracts. The update expands required disclosures in order to increase the transparency of significant estimates made in measuring the liability for unpaid losses and loss expenses, improve comparability and facilitate financial statement users' analysis of the cash flows arising from re/insurance contracts and the development of loss reserve estimates. The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within annual periods beginning after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this guidance on its disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2015, the FASB issued updated guidance on disclosures for investments in certain entities that calculate net asset value (NAV) per share (or its equivalent). The update eliminates the requirement to categorize investments measured using the NAV practical expedient in the fair value hierarchy table. The guidance is applicable retrospectively and is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact of the adoption of this guidance on its disclosures.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PartnerRe Ltd. (PartnerRe or the Company) predominantly provides reinsurance and certain specialty insurance lines on a worldwide basis through its principal wholly-owned subsidiaries, including Partner Reinsurance Company Ltd., Partner Reinsurance Europe SE, Partner Reinsurance Company of the U.S. and, effective April 1, 2015, Partner Reinsurance Asia Pte. Ltd (PartnerRe Asia). Risks reinsured include, but are not limited to, property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, mortality, longevity, accident and health and alternative risk products. The Company’s alternative risk products include weather and credit protection to financial, industrial and service companies on a worldwide basis.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2015, the Company announced that PartnerRe Asia was licensed by the Monetary Authority of Singapore (MAS) to operate as a non-life and life reinsurer in Singapore. As of April 1, 2015, PartnerRe Asia became the principal reinsurance carrier for the Company’s business underwritten in the Asia Pacific region. The establishment of PartnerRe Asia has enabled the Company's Asian reinsurance operations to be consolidated into one regional, well-capitalized entity and will support its growing underwriting presence in the region.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 25, 2015, the Company entered into an Agreement and Plan of Amalgamation (as subsequently amended, the Amalgamation Agreement) with Axis Capital Holdings Limited, a Bermuda exempted company (AXIS), pursuant to which the Company would amalgamate with AXIS (Amalgamation), and the two companies would continue as a single Bermuda exempted company. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 14, 2015, the Company announced receipt of an unsolicited proposal from EXOR S.p.A. (EXOR), a European investment company controlled by the Agnelli family, to acquire </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the common shares of the Company for </font><font style="font-family:inherit;font-size:10pt;">$130</font><font style="font-family:inherit;font-size:10pt;"> per share in cash. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 3, 2015, the Company and AXIS amended the Amalgamation Agreement to allow the Company to pay a one-time special dividend of </font><font style="font-family:inherit;font-size:10pt;">$11.50</font><font style="font-family:inherit;font-size:10pt;"> per share to PartnerRe common shareholders in connection with the closing of the Amalgamation (one-time special dividend) and to increase the termination fee from </font><font style="font-family:inherit;font-size:10pt;">$250 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$280 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 12, 2015, the Company announced receipt of a revised proposal from EXOR to acquire all of the outstanding common shares of the Company for </font><font style="font-family:inherit;font-size:10pt;">$137.50</font><font style="font-family:inherit;font-size:10pt;"> per share in cash. </font><font style="font-family:inherit;font-size:10pt;">EXOR requested that the Board declare EXOR's proposal to be "reasonably likely a superior proposal" as a pre-condition to any further negotiations, which was rejected by the Company's Board. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 7, 2015, EXOR enhanced the terms of its proposal by providing (i) a </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> basis points increase in the preferred share dividend rate, (ii) call protection until 2021, and (iii) a commitment to limit distributions to common shareholders to an amount not greater than </font><font style="font-family:inherit;font-size:10pt;">67%</font><font style="font-family:inherit;font-size:10pt;"> of net income until December 31, 2020.  </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 16, 2015, the Company and AXIS amended the Amalgamation Agreement further to increase the one-time special dividend to be paid by the Company to its common shareholders to </font><font style="font-family:inherit;font-size:10pt;">$17.50</font><font style="font-family:inherit;font-size:10pt;"> per share and, subject to certain conditions, to match the economic terms proposed by EXOR on July 7, 2015 in relation to the Company's preferred shares.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 20, 2015, EXOR announced an increase in its proposal to acquire </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the common shares of the Company for </font><font style="font-family:inherit;font-size:10pt;">$137.50</font><font style="font-family:inherit;font-size:10pt;"> per share in cash by adding a special dividend of </font><font style="font-family:inherit;font-size:10pt;">$3.00</font><font style="font-family:inherit;font-size:10pt;"> per share to be paid by the Company to its common shareholders pre-closing.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 21, 2015, the Company announced that it had determined that EXOR's enhanced proposal of July 20, 2015 would reasonably be likely to result in a superior proposal in accordance with the Amalgamation Agreement. As a result, the Board sought to engage in negotiations with EXOR, and offered EXOR the opportunity to conduct due diligence, to determine whether EXOR's proposal could be improved both in price and terms. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 3, 2015, the Company announced that it had reached a definitive agreement with EXOR under which EXOR would acquire all of the outstanding common shares of PartnerRe for an all-cash consideration of </font><font style="font-family:inherit;font-size:10pt;">$137.50</font><font style="font-family:inherit;font-size:10pt;"> per share and a special pre-closing dividend of </font><font style="font-family:inherit;font-size:10pt;">$3.00</font><font style="font-family:inherit;font-size:10pt;"> per share. The transaction would be effected by a merger of Pillar Ltd., a wholly owned subsidiary of EXOR N.V., with and into the Company, with the Company continuing as the surviving company and a wholly owned subsidiary of EXOR N.V. Pursuant to the terms of the merger agreement (Merger Agreement), each PartnerRe common share issued and outstanding immediately prior to the effective time of the merger shall (i) automatically be canceled and converted into the right to receive the acquisition consideration and (ii) be entitled to receive the special dividend. The declaration of the special dividend will occur prior to the effective time of the merger and is subject to compliance with the Bermuda Companies Act 1981 and will be conditional and contingent upon the issuance of the certificate of merger by the Bermuda Registrar of Companies (referred to as the effective time of the merger). The Merger Agreement is subject to approval by the Company's shareholders on November 19, 2015, regulatory clearance and other customary closing conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the execution of the Merger Agreement, the Company and AXIS terminated the Amalgamation Agreement. On August 3, 2015, in accordance with the terms of the Amalgamation Agreement, the Company paid a termination fee and reimbursement of expenses to AXIS of </font><font style="font-family:inherit;font-size:10pt;">$315 million</font><font style="font-family:inherit;font-size:10pt;"> which is included within Other expenses in the Condensed Consolidated Statements of Operations for the three months and </font><font style="font-family:inherit;font-size:10pt;">nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">September 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While Management believes that the amounts included in the Condensed Consolidated Financial Statements reflect its best estimates and assumptions, actual results could differ from those estimates. The Company’s principal estimates include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unpaid losses and loss expenses;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Policy benefits for life and annuity contracts;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross and net premiums written and net premiums earned;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of deferred acquisition costs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Recoverability of deferred tax assets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation of goodwill and intangible assets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:47px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:23px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation of certain assets and derivative financial instruments that are measured using significant unobservable inputs.</font></div></td></tr></table></div>

Files In Submission

Name	View Source	Status
0000911421-15-000046-index-headers.html	Edgar Link	pending
0000911421-15-000046-index.html	Edgar Link	pending
0000911421-15-000046.txt	Edgar Link	pending
0000911421-15-000046-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pre-20150930.xml	Edgar Link	completed
pre-20150930.xsd	Edgar Link	pending
pre-20150930_cal.xml	Edgar Link	unprocessable
pre-20150930_def.xml	Edgar Link	unprocessable
pre-20150930_lab.xml	Edgar Link	unprocessable
pre-20150930_pre.xml	Edgar Link	unprocessable
q3201510-q.htm	Edgar Link	pending
q32015exhibit101.htm	Edgar Link	pending
q32015exhibit15.htm	Edgar Link	pending
q32015exhibit311.htm	Edgar Link	pending
q32015exhibit312.htm	Edgar Link	pending
q32015exhibit32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zwieneramendedandrest_image1.gif	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PREJF
PARTNERRE LTD Stock $prejf

2015 Q4 Form 10-Q Financial Statement

#000091142115000046 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PREJF PARTNERRE LTD Stock $prejf

2015 Q4 Form 10-Q Financial Statement

#000091142115000046 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PREJF
PARTNERRE LTD Stock $prejf